D-Mannose Market Set for Steady Growth to US$ 2.15 Billion by 2033, Driven by Rising UTI Prevention Demand and Expanding Natural Health Supplement Adoption, with Danisco (DuPont), Douglas Laboratories, and NOW Foods Leading the Global Competitive Landscap

The Global D-Mannose Market reached US$ 1.21 billion in 2025 and is expected to reach US$ 2.15 billion by 2033, growing with a CAGR of 7.5% during the forecast period 2026-2033 as global consumers and healthcare sectors accelerate the adoption of natural, low-glycemic sugar alternatives for urinary tract infection (UTI) management, preventive health, and functional food applications.

Growth is supported by surging demand across key application areas such as Nutritional supplements (dominant segment), functional food & beverages, pharmaceuticals (for UTI prevention and carbohydrate-deficient glycoprotein syndrome), and animal feed, driven by massive consumer preference for natural alternatives to antibiotics, rising prevalence of UTIs (especially in women), increasing awareness of preventive wellness, and the shift toward low-calorie, low-glycemic products amid growing cases of diabetes, obesity, and lifestyle diseases. The market is further strengthened by clinical evidence supporting D-Mannose's role in preventing bacterial adhesion in the urinary tract, its occurrence in natural sources like cranberries, and strong demand for clean-label ingredients. Additionally, advancements in product forms (powder, capsules, tablets with capsules and tablets gaining traction for convenience and absorption), new formulations combined with cranberry extracts, and innovations in bioavailability continue to accelerate market expansion. Expanding nutraceutical and functional food ecosystems in leading economies, particularly in North America (largest share due to high health awareness and major manufacturers) and Asia-Pacific (fastest growing), along with rising investments from supplement and food ingredient companies, further contribute to the broad adoption of D-Mannose worldwide.

Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/d-mannose-market?sindhuri

D-Mannose Market: Competitive Intelligence Danisco (DuPont), Naturesupplies, Douglas Laboratories, Sweet Cures, Hebei Huaxu Pharmaceutical Co., Ltd., Huachang Pharmaceutical, Hubei Widely Chemical Technology Co., Ltd., Specom Biochemical Co., Ltd., Amresco LLC, and Ferro Pfanstiehl Laboratories, Inc. are the major global players shaping the competitive landscape of the D-Mannose Market. These companies provide a wide portfolio of D-Mannose solutions including high-purity powder, capsules, tablets, and blended formulations (often with cranberry extract), designed to enable breakthroughs in UTI prevention, blood sugar management, low-calorie functional foods, and natural wellness applications.

The D-Mannose Market is primarily driven by the increasing global demand for natural alternatives to antibiotics and low-glycemic ingredients, alongside the rising shift toward preventive healthcare and functional nutrition for next-generation wellness applications. Growing concerns over recurrent UTIs, antibiotic resistance, diabetes, obesity, and the desire for clean-label, naturally derived products are accelerating the adoption of D-Mannose as a foundational enabler. Additionally, clinical validation of its efficacy, expansion of Nutritional supplements channels, and consumer preference for convenient formats are further fueling market growth. D-Mannose plays a crucial role in preventing bacterial adhesion in the urinary tract, supporting metabolic health with minimal impact on blood sugar and insulin, and serving as a versatile ingredient in supplements and functional foods, making it an essential component in modern nutraceutical, pharmaceutical, and food & beverage ecosystems.

Competitive differentiation among these companies is driven by innovation in high-purity extraction, development of convenient capsule and tablet formats, synergistic blends with cranberry for enhanced UTI protection, and strong focus on clean-label and clinically supported products. Danisco (DuPont) and Douglas Laboratories emphasize premium, science-backed formulations with broad distribution, while Naturesupplies and Sweet Cures focus on specialized UTI prevention products. Hebei Huaxu and Hubei Widely leverage cost-effective manufacturing for high-volume supply. Strategic focus areas include launch of new combination products (D-Mannose + cranberry), investment in improved bioavailability and powder solubility, expansion into high-growth Asia-Pacific markets, capacity increases to meet rising supplement demand, partnerships with nutraceutical brands, and increasing penetration in high-growth segments such as Nutritional supplements and functional foods driven by rising demand for natural UTI management, low-calorie alternatives, and preventive health solutions among women, health-conscious consumers, and diabetic populations.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/d-mannose-market?sindhuri

Recent Key Developments - United States & North America
✅ June 2025: NOW Foods expanded its urinary tract health supplement portfolio with enhanced D-mannose formulations combined with cranberry and probiotics, targeting rising consumer demand for preventive wellness products in the U.S.
✅ May 2025: Nestlé Health Science strengthened its nutraceutical pipeline by increasing investment in clinically backed urinary health ingredients, including D-mannose-based blends for recurrent UTI management support.
✅ 2025: Growing awareness of urinary tract health, especially among women and aging populations, significantly boosted demand for D-mannose supplements across retail, pharmacy, and e-commerce channels in North America.

Recent Key Developments - Europe & Asia-Pacific
✅ July 2025: Kyowa Hakko Bio expanded production capacity for functional carbohydrate-based ingredients, supporting increased global supply of D-mannose for Nutritional supplements manufacturers across Europe and APAC.
✅ Early 2026: Blackmores Limited enhanced its urinary tract health product line in Australia and Southeast Asia, integrating D-mannose with herbal and probiotic formulations for holistic wellness solutions.
✅ 2025: Rising preference for natural and plant-derived ingredients, along with increasing UTI prevalence, drove strong adoption of D-mannose supplements in Europe and Asia-Pacific nutraceutical markets.

Recent Key Developments - Product & Technology Innovation
✅ 2025: Combination Formulations: Growing development of D-mannose blends with probiotics, cranberry extract, and vitamin C improved urinary tract defense and expanded preventive healthcare applications.
✅ Clinically Supported Nutraceuticals: Increased clinical research validating D-mannose efficacy for UTI recurrence prevention strengthened its positioning in evidence-based supplement markets.
✅ Clean-Label & Vegan Products: Rising demand for plant-based, non-GMO, and allergen-free D-mannose supplements accelerated innovation in clean-label urinary health formulations across global markets.

Find the Right Partner to Accelerate Your Growth Today with Our Latest Report:
https://www.datamintelligence.com/partner-identification-enquiry/d-mannose-market?sindhuri

M&A / Strategic Activity
Recent strategic acquisitions, partnerships, and ecosystem developments shaping the D-Mannose Market:

NOW Health Group - Expansion in urinary health supplement portfolio
In 2025, NOW Foods strengthened its nutraceutical portfolio through expanded product lines focused on D-Mannose-based urinary tract health supplements, targeting preventive wellness and natural infection management solutions.
Swanson Health Products - Strategic growth in natural UTI support supplements
Swanson expanded its partnerships with ingredient suppliers to secure high-purity D-Mannose, strengthening its position in the women's health and urinary tract wellness segment.
Jarrow Formulas - Ecosystem expansion in probiotic and urinary health combinations
Jarrow Formulas enhanced its nutraceutical portfolio by integrating D-Mannose with probiotic formulations aimed at improving urinary tract microbiome balance and reducing infection recurrence.
Solabia Group - Strategic ingredient sourcing and biotechnology expansion
Solabia expanded its natural ingredient production capabilities, strengthening its supply chain for plant-derived D-Mannose used in Nutritional supplements and functional foods.
Douglas Laboratories (Atrium Innovations / Nestlé Health Science) - Clinical nutrition focus
Douglas Laboratories expanded clinical nutrition offerings incorporating D-Mannose for urinary tract health support in medical-grade supplement formulations.

New Product/Service Launches & Deployments
Recent product innovations and deployments in the D-Mannose space:

NOW Foods - Advanced D-Mannose powder and capsule formulations
NOW Foods launched high-purity D-Mannose supplements designed to support urinary tract health and reduce bacterial adhesion in the bladder.
Nature's Way - Cranberry and D-Mannose combination supplements
Nature's Way introduced blended formulations combining cranberry extract and D-Mannose to enhance urinary tract infection prevention and overall urinary health support.
Pure Encapsulations - Clinical-grade D-Mannose products
Pure Encapsulations expanded its nutraceutical line with hypoallergenic D-Mannose supplements targeted at sensitive individuals and clinical nutrition applications.
Solaray - Enhanced urinary tract support formulations
Solaray launched D-Mannose-based capsules combined with herbal extracts to support urinary tract cleansing and immune health.
Life Extension - Targeted urinary microbiome support products
Life Extension introduced D-Mannose formulations integrated with probiotics and antioxidants for improved urinary tract microbiome balance.

R&D & Technological Advancements
Mechanism of Action Optimization in UTI Prevention
R&D is focused on improving understanding of D-Mannose's role in preventing bacterial adhesion, particularly against E. coli in urinary tract infections.
Combination Therapies with Probiotics and Cranberry Extract
Research is increasingly exploring synergistic formulations combining D-Mannose with probiotics, cranberry polyphenols, and herbal extracts for enhanced urinary health benefits.
Bioavailability and Absorption Enhancement Technologies
Advancements in formulation science are improving D-Mannose absorption rates and systemic availability in Nutritional supplements forms.
Clinical Nutrition and Evidence-Based Supplementation
Growing clinical studies are validating D-Mannose efficacy in recurrent UTI prevention, particularly among women and elderly populations.
Personalized Nutrition & Microbiome-Based Supplement Design
Emerging R&D trends are focusing on personalized urinary health supplements based on individual microbiome profiles and infection risk factors.

Market Drivers & Emerging Trends
» Rising prevalence of urinary tract infections (UTIs), especially among women and elderly populations, driving demand for preventive supplements.
» Increasing preference for natural and non-antibiotic solutions supporting urinary health management.
» Growing awareness of microbiome health and its role in urinary tract function.
» Expansion of e-commerce and direct-to-consumer nutraceutical sales channels boosting market accessibility.
» Rising adoption of combination supplements (D-Mannose + cranberry + probiotics) for enhanced efficacy.
» Increasing clinical validation of D-Mannose strengthening its position in evidence-based nutraceuticals.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=d-mannose-market?sindhuri

Segments Covered in the Global D-Mannose Market:
By Form
The market is segmented into powder (55%), capsules (30%), and tablets (15%). Powder dominates the segment due to its high flexibility in dosing, faster absorption, and wide application in Nutritional supplements and functional formulations. Capsules follow closely as they offer convenience, precise dosing, and better consumer compliance. Tablets hold a smaller share but remain relevant due to their stability, portability, and ease of mass production in nutraceutical and pharmaceutical applications.

By End-Use
The market is divided into Nutritional supplements (45%), pharmaceuticals (30%), functional food (15%), animal feed (5%), and others (5%). Nutritional supplements dominate the segment due to increasing consumer awareness of urinary tract health and preventive healthcare trends. Pharmaceuticals hold a strong share driven by the use of D-mannose in managing urinary tract infections (UTIs) and related conditions. Functional foods are growing steadily with rising demand for health-enhancing ingredients in everyday nutrition, while animal feed and other applications represent niche but emerging opportunities.

By Region
North America - 35% Share
North America leads the market due to high consumer awareness of urinary tract health supplements, strong nutraceutical industry presence, and increasing adoption of preventive healthcare products in the United States and Canada.

Europe - 25% Share
Europe is driven by rising demand for natural health supplements, strong regulatory support for nutraceuticals, and increasing preference for plant-based and functional ingredients across countries such as Germany, the UK, France, and Italy.

Asia-Pacific - 28% Share
Asia-Pacific is expanding rapidly due to growing health consciousness, rising disposable incomes, and increasing adoption of Nutritional supplements in countries such as China, India, Japan, and Southeast Asia.

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription?sindhuri
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact:
Fabian
DataM Intelligence 4market Research LLP 6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.